You just read:

Esketamine Receives Breakthrough Therapy Designation from U.S. Food and Drug Administration for Major Depressive Disorder with Imminent Risk for Suicide

News provided by

Janssen Pharmaceutical Companies

Aug 16, 2016, 09:00 ET